Why Beacon?
Discover how Beacon Gene Therapy enables data-driven insight that will accelerate your Gene Therapy development decisions.
- Validate Gene Therapy asset potential with insights on competitor programs, clinical outcomes, and market activity
- Explore Gene Therapy design strategies from delivery systems and editing technology to gene/mutation and site of delivery
- Benchmark your research with validated preclinical data, including publication summaries, and links to conference abstracts and posters
- Optimize clinical trial design by analyzing trial endpoints, outcomes, and regulatory precedents, to accelerate progression into the clinic
- Find the right partners in a competitive market, by tracking new companies, collaborations, and licensing deals, as they emerge
Join 24/25 top Pharma companies who use Beacon to accelerate and improve their drug development decisions.
Request Beacon Gene Therapy Demonstration
Please submit the form below to request your personalized demonstration of the Beacon Gene Therapy platform. A member of our specialized team will be in touch shortly to schedule a time that suits you.
How is Beacon Gene Therapy Different?
- A Unique Gene Therapy Dataset: Comprehensive & accurate, preclinical and clinical, Gene Therapy drug, trial and commercial data to inform your Gene Therapy development decisions
- In Depth Preclinical Data: Including preclinical publication summaries, and links to conference abstracts and posters
- Proprietary Ontologies: Market leading standardized ontologies, enabling you to easily segment the Gene Therapy drug development landscape, to quickly find the data that matters to you
- Human Intelligence: Beacon Gene Therapy data is manually curated by sector specialist analysts, to ensure data accuracy and integrity
Search